🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jeffrey King

Washington University in St. Louis

ORCID: 0009-0009-4581-1935
Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 4 papers. Top paper: “Telemedicine and cystic fibrosis: Do we still need face-to-face clinics?”.

Telemedicine and cystic fibrosis: Do we still need face-to-face clinics?

Paediatric Respiratory Reviews(2021)10.1016/j.prrv.2021.05.002
N/A
0.584DataRank · unranked
48 citations

K. Dick, Sarah Ollosson, D. Jones, Holly Mattock, Siân Bentley +7 more

The effects of multifactorial pharmacist-led intervention protocol on medication optimisation and adherence among patients with type 2 diabetes: A randomised control trial

F1000Research(2024)10.12688/f1000research.146517.1
N/A
0.330DataRank · unranked
8 citations

Luai A. Ahmed, Jeffrey King, Syed Abubackar, Ahmed Al Juboori, Nirmin A. Mansour +2 more

Phase I-II Trial of Early Azacitidine after Matched Unrelated Donor Hematopoietic Cell Transplantation

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.08.017
N/A
0.165DataRank · unranked
2 citations

Jaebok Choi, Matthew Cooper, Jeffrey King, Mark A. Fiala, Jingxia Liu +13 more

Continuous Elotuzumab, Pomalidomide, and Dexamethasone Maintenance Following Second Autologous Transplantation for Multiple Myeloma: Results of a Prospective Phase 2 Multicenter Trial

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.09.014
N/A
0.104DataRank · unranked
1 citations

Mark A. Fiala, Marie Kirchmeyer, Jeffrey King, Feng Gao, Mark A. Schroeder +5 more